CONTENTS:
- Lower risk drinking guidelines and the 'no safe level' message: Finding a balance in risk communication [Editorial]. Burton R., Nicholls J., p. 1630-1632.
- On the need and contents of a specific addiction recovery research agenda [Addiction opinion and debate]. White W.L., Kelly J.F., p. 1633-1642.
- Recovery beyond the individual: Toward a place-based paradigm for recovery science. Burns V.F., p. 1643-1644.
- A manifesto for theoretical innovation. Field M., p. 1645-1646.
- Further expanding the addiction recovery research agenda: Institutions, populations and workforce. Vest N., p. 1647-1648.
- Advancing addiction science through the study of recovery trajectories. Ivers J.H., p. 1649-1650.
- Enhancing recovery science: From theory to life stage and context, to subpopulations and new paradigmatic thinking. Kelly J.F., White W.L., p. 1651-1652.
- The prevalence of cannabidiol (CBD) use in North America and Europe: A meta-analysis. Weidberg S., Iza-Fernandez C., Aleman-Moussa L., Krotter A., Gonzalez-Roz A., p. 1653-1670.
- Medication effects on cue-induced craving in the human laboratory are associated with return to heavy drinking in randomized clinical trials for alcohol use disorder: A follow-up meta-analysis. Nieto S.J., Du H., Meredith L.R., Donato S., Baskerville W.A., McManus K.R., et al., p. 1671-1680.
- Commentary on Nieto et al.: The heterogeneity of drug craving and considerations as a treatment endpoint. Strickland J.C., Bergeria C.L., Acuff S.F., p. 1681-1682.
- Genetic overlap of chronic pain, musculoskeletal-specific pain, substance use disorders and substance use consumption: Common addiction and substance-specific effects. Rader L., Zorina-Lichtenwalter K., Hatoum A.S., Stallings M.C., Wager T.D., Friedman N.P., p. 1683-1698.
- Comparative effectiveness of social-contextual treatments for improving substance-related problems among Black adults: An individual-level data synthesis. Espinosa A., Haeny A.M., Ruglass L.M., McCuistian C., Vena A., Roundtree C., et al., p. 1699-1708.
- A genetically informed cross-lagged twin study of the longitudinal association between addiction-related behaviors and obesity. Qi B., Highland H.M., Graff M., Bulik C.M., Rhee S.H., Stallings M.C., et al., p. 1709-1720.
- Does the total consumption model apply to cannabis use? Norström T., Leifman H., p. 1721-1730.
- Commentary on Norström and Leifman: A welcome contribution and an invitation to further research. Rossow I., p. 1731-1732.
- Availability of nitazenes via cryptomarkets and surface web shops: An observational study. Man N., Barratt M.J., Sutherland R., Bruno R., Graham C., Sadaphale V., et al., p. 1733-1746.
- Impact of enhanced practices on opioid overdose deaths: A community-based modeling approach. Barbosa C., Chen Q., Sahinkoc M., Zarkin G.A., Dowd W., Villani J., et al., p. 1747-1760.
- The prevalence and correlates of prescription stimulant diversion in a large, multi-institutional, cross-sectional sample of US post-secondary students regularly taking prescription stimulants. Aluri J., Mojtabai R., p. 1761-1769.
- Cannabis dispensary exposure and smoked, vaped and edible cannabis use among young adults: Comparison of web-scraped and government-maintained registries. Harlow A.F., Williams M.P., Pacula R.L., Leventhal A.M., Pedersen E.R., Cockburn M.G., et al., p. 1770-1780.
- Changes over time in hallucinogen-related emergency department visits in Ontario, Canada. Myran D.T., MacDonald-Spracklin R., Levesque A.R., Pugliese M., Fiedorowicz J.G., McDonald A.J., et al., p. 1781-1793.
- Theorizing causality: A qualitative study of xylazine-related wound diversity and perceived etiology among people who inject drugs. German D., Villarroel K., Denney M., Guta A., Evans J., Bienert J., et al., p. 1794-1807.
- Commentary on German et al.: Qualitative inquiry reduces lags in scientific discovery-to-practice by recognizing the living expertise of people who use drugs. Reed M.K., p. 1808-1809.
- Diagnostic validity of Addictions Neuroclinical Assessment indices for alcohol use disorder: Findings from an observational case-control study. Garber M.L., McIntyre-Wood C., Elsayed M., Amlung M.T., Sweet L.H., MacKillop J., p. 1810-1823.
- Which personality traits are necessary conditions for problematic alcohol use? Insights from a 23-year longitudinal study. Giugovaz A., Prinzie P., Lutz M.C., Franken I.H.A., Marchetti I., p. 1824-1835.
- Nation-wide trends in prevalence and mortality of high-risk drinking among adult men with and without disabilities in South Korea between 2009 and 2017. Park B.H., Kim S.Y., Yeob K.E., Kim Y.Y., Park J.H., p. 1836-1849.
- Long-term effects of a peer-led Brief Alcohol Screening and Intervention for College Students (BASICS) intervention to reduce alcohol consumption among Spanish university students: A 12-month randomised controlled trial. Lavilla-Gracia M., Pueyo-Garrigues M., Alfaro-Diaz C., Canga-Armayor N., p. 1850-1862.
- Low and no alcohol availability and sales in small retailers in Great Britain: A geographic longitudinal analysis from 2018 to 2022. Valiente R., Tunstall H., Wilson L.B., Gillespie D., Pearce J., Shortt N.K., p. 1863-1875.
- Determining the impact of cannabis use on tobacco cessation: Results from a prospective non-randomized tobacco treatment trial. McClure E.A., Baker N., Tomko R.L., Walters K.J., Chapman E., Carpenter M.J., et al., p. 1876-1887.
- Personalizing smoking cessation pharmacotherapy using neuroaffective reactivity profiles: A randomized controlled trial. Versace F., Green C.E., Cui Y., Robinson J.D., Deweese M.M., Minnix J.A., et al., p. 1888-1898.
- Titration of nicotine intake in smokers switching to reduced nicotine content cigarettes with access to alternative nicotine systems: Secondary analysis of a randomized clinical trial. Benowitz N.L., Hu J., Luo X., McClernon F.J., Tidey J., Strasser A.A., et al., p. 1899-1906.
- Direct gambling marketing, direct harm: A randomised experiment. Rockloff M., Browne M., Hing N., Russell A.M.T., Rawat V., Newall P., p. 1907-1919.
- Underage deaths associated with substance-related harm in Taiwan: A national 10-year study. Wei S.Y., Hu H.Y., Pan C.H., p. 1920-1926.
- Prevalence differences in lifetime methamphetamine and heroin use among American Indian reservation youth from 2015 to 2024. Morse J.L., Gray B.A., Emery N.N., Crabtree M.A., Swaim R.C., Prince M.A., p. 1927-1933.
- Regional perspectives: Substance use related problems in Ethiopia. Yimer T.M., Fekadu W., Leung J., Mihretu A., Teferra S., p. 1934-1941.
- Clarifying Selected Citations and Interpretations in 'Underage deaths associated with substance-related harm in Taiwan: A national 10-year study'. Yang J.M., Wei L.C., p. 1944-1945.
- Forensic interpretation and age distribution patterns in substance-related child deaths. Wei S.Y., Pan C.H., p. 1946.